FIELD: biotechnology.
SUBSTANCE: present invention relates to a method of producing conditionally active proteins. Invention also discloses criteria for selecting source proteins for detection methods and formats of said proteins.
EFFECT: invention enables genetic engineering to produce therapeutic and diagnostic molecules of proteins which are more active under the abberant condition than under normal physiological condition.
19 cl, 1 dwg, 4 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDITIONALLY ACTIVE POLYPEPTIDES | 2016 |
|
RU2735023C2 |
| CONDITIONALLY ACTIVE CHIMERIC ANTIGENIC RECEPTORS FOR MODIFIED T CELLS | 2016 |
|
RU2759957C2 |
| CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS | 2015 |
|
RU2764074C2 |
| IDENTIFICATION, ASSESSMENT, AND THERAPY OF CANCERS WITH INNATE OR ACQUIRED RESISTANCE TO ALK INHIBITORS | 2011 |
|
RU2589834C2 |
| METHODS AND FORMULATIONS FOR PRODUCING LYMPHOCYTES AND FOR CONTROLLED INCREASE THEREOF | 2017 |
|
RU2755059C2 |
| POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE | 2004 |
|
RU2372356C2 |
| HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 | 2004 |
|
RU2518324C2 |
| MODIFIED VON WILLEBRAND FACTOR WITH PROLONGED HALF-CYCLE IN VIVO, USING IT AND METHODS FOR PREPARING | 2009 |
|
RU2528855C2 |
| NEW GENES CODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2423525C2 |
| NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING DISEASES ASSOCIATED WITH MUSCULAR ATROPHY | 2016 |
|
RU2733492C2 |
